Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Giripladib vs Naproxen in Knee Osteoarthritis
NCT00396955Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Nov 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of giripladib in osteoarthritis (OA), sponsored by Pfizer. Started Nov 2006; status: terminated.
02
Drugs
giripladib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00396955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396955.